Frequency Therapeutics, Inc

(NASDAQ:FREQ)

Latest On Frequency Therapeutics, Inc (FREQ):

Date/Time Type Description Signal Details
2023-05-12 19:01 ESTNewsFrequency Therapeutics GAAP EPS of -$0.55 misses by $0.11N/A
2023-03-10 18:33 ESTNewsFrequency Therapeutics GAAP EPS of -$0.49 beats by $0.14N/A
2023-02-13 15:34 ESTNewsFrequency crashes ~75% on abandoning hearing loss programs as trial fails; cuts ~55% jobsN/A
2022-12-15 21:49 ESTNewsFrequency starts dosing in phase 1b trial of hearing loss therapyN/A
2022-11-09 00:35 ESTNewsFrequency Therapeutics GAAP EPS of -$0.55N/A
2022-11-03 03:56 ESTNewsFrequency climbs 16% as Baird initiates at Outperform ahead of readout for lead assetN/A
2022-08-10 10:40 ESTNewsFrequency Therapeutics GAAP EPS of -$0.61N/A
2022-05-04 19:39 ESTNewsFrequency Therapeutics GAAP EPS of -$0.67N/A
2022-03-15 14:51 ESTNewsFrequency Therapeutics GAAP EPS of -$0.62 misses by $0.98N/A
2021-11-15 18:32 ESTNewsFrequency Therapeutics reports Q3 resultsN/A
2021-10-21 23:44 ESTNewsFrequency gets dosing underway in mid-stage Sensorineural Hearing Loss studyN/A
2021-09-22 17:30 ESTNewsNew data suggests Frequency Therapeutics' drug regenerates hearingN/A
2021-09-22 17:30 ESTNewsFibroGen downgraded, PMV Pharma upgraded in ratings reshuffle at Goldman SachsN/A
2021-08-12 10:00 ESTNewsFrequency Therapeutics EPS misses by $0.01, beats on revenueN/A
2021-04-21 12:00 ESTNewsFrequency Therapeutics: A Look At What's Next After A Disappointing Data ReadoutN/A
2021-03-29 23:36 ESTNewsFrequency Therapeutics EPS misses by $0.02, beats on revenueN/A
2021-03-23 17:03 ESTNewsFrequency Therapeutics (FREQ) shares plunge 73% after FX-322's four-dose regime fails to improve hearing lossN/A
2021-02-23 07:53 ESTNewsFrequency Therapeutics' FX-322 shows positive effect in hearing lossN/A
2021-02-11 09:53 ESTAnalyst RatingThe Analyst Target Price has increased from $53.67 to $60.33.Buy
2021-01-28 09:47 ESTAnalyst RatingThe Analyst Target Price has increased from $47 to $53.67.Buy
2021-01-27 09:43 ESTNewsFrequency Therapeutics upgraded to Overweight at JPMorganN/A
2020-12-23 18:48 ESTAnalyst RatingThe Analyst Target Price has increased from $36.33 to $47.Buy
2020-12-18 23:34 ESTNewsFrequency Therapeutics to host investor event in early January next yearN/A
2020-12-17 15:01 ESTAnalyst RatingThe Analyst Target Price has increased from $32.33 to $36.33.Neutral
2020-12-04 18:49 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 15:31 ESTAnalyst RatingThe Analyst Target Price has decreased from $35 to $32.33.Neutral
2020-11-18 04:10 ESTNewsFrequency Therapeutics EPS beats by $0.16, beats on revenueN/A
2020-11-17 23:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 14:31 ESTEarnings EstimateAn EPS average of -$0.31 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-10 03:30 ESTNewsFrequency Therapeutics Is An Interesting Speculative Play Ahead Of Phase 2 ResultsN/A
2020-11-07 19:22 ESTFinancialsCompany financials have been released.Neutral
2020-11-03 19:09 ESTInsider TradeDavid L. Lucchino has directly disposed of 2,749 shares and currently holds 339,514 shares.Sell
2020-11-03 19:09 ESTInsider TradeDavid L. Lucchino has directly disposed of 12,965 shares and currently holds 342,263 shares.Sell
2020-10-14 16:58 ESTInsider TradeChristopher R. Loose has directly disposed of 8,000 shares and currently holds 87,782 shares.Sell
2020-10-08 20:23 ESTFinancialsCompany financials have been released.Neutral
2020-10-08 18:13 ESTInsider TradeChristopher R. Loose has directly disposed of 8,000 shares and currently holds 95,782 shares.Sell
2020-10-08 18:13 ESTInsider TradeChristopher R. Loose has directly disposed of 8,000 shares and currently holds 103,782 shares.Sell
2020-10-08 18:13 ESTInsider TradeChristopher R. Loose has directly disposed of 8,000 shares and currently holds 111,782 shares.Sell
2020-10-05 17:38 ESTInsider TradeChristopher R. Loose has directly disposed of 8,000 shares and currently holds 119,782 shares.Sell
2020-10-05 17:38 ESTInsider TradeChristopher R. Loose has directly disposed of 8,000 shares and currently holds 127,782 shares.Sell
2020-10-05 17:38 ESTInsider TradeChristopher R. Loose has directly disposed of 8,000 shares and currently holds 135,782 shares.Sell
2020-10-05 16:53 ESTInsider TradeDavid L. Lucchino has directly disposed of 4,878 shares and currently holds 355,228 shares.Sell
2020-10-05 16:53 ESTInsider TradeDavid L. Lucchino has directly disposed of 10,838 shares and currently holds 360,106 shares.Sell
2020-09-26 16:12 ESTFinancialsCompany financials have been released.Neutral
2020-09-25 09:43 ESTInsider TradeChristopher R. Loose has directly disposed of 24 shares and currently holds 143,782 shares.Sell
2020-09-25 09:42 ESTInsider TradeChristopher R. Loose has directly disposed of 2,606 shares and currently holds 143,806 shares.Sell
2020-09-25 09:42 ESTInsider TradeChristopher R. Loose has directly disposed of 1,870 shares and currently holds 146,412 shares.Sell
2020-09-17 16:57 ESTNewsFrequency Therapeutics Has A Strong Scientific Rationale And An Upcoming Binary CatalystN/A
2020-09-17 08:51 ESTFinancialsCompany financials have been released.Neutral

About Frequency Therapeutics, Inc (FREQ):

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in phase 2a clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. Frequency Therapeutics, Inc. has a licencse and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322. Frequency Therapeutics, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

FREQ Quotes by TradingView

See Advanced Chart

General

  • Name Frequency Therapeutics, Inc
  • Symbol FREQ
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Fiscal Year EndDecember
  • IPO Date2019-10-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.frequencytx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 42.63
  • Price/Book (Most Recent Quarter) 6.78
  • Enterprise Value Revenue 35.64
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.31
  • Profit Margin -69%
  • Operating Margin -75%
  • Return on Assets -7%
  • Return on Equity -15%
  • Revenue 31.74 million
  • Earnings Per Share -$0.64
  • Revenue Per Share $1.03
  • Gross Profit 12.95 million
  • Quarterly Earnings Growth -53.6%
View More

Highlights

  • Market Capitalization 1.28 billion
  • EBITDA -22584000
  • Analyst Target Price $60.33
View More

Share Statistics

  • Shares Outstanding 33.73 million
  • Shares Float 25.85 million
  • % Held by Insiders 1249%
  • % Held by Institutions 57.92%
  • Shares Short 5.32 million
  • Shares Short Prior Month 3.93 million
  • Short Ratio 17.71
  • Short % of Float 17%
  • Short % of Shares Outstanding 16%
View More

Technicals

  • 52 Week High $58.37
  • 52 Week Low $14.5
  • 50 Day Moving Average 46.37
  • 200 Day Moving Average 31.73
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Frequency Therapeutics, Inc (FREQ) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Frequency Therapeutics, Inc (FREQ) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$0.16-$0.3250.02%
2020-06-302020-08-12$8.52 million-$0.19-$0.2212.96%
2020-03-312020-05-14$7.26 million-$0.16-$0.2534.69%
2019-12-312020-03-26$4.71 million-$0.19$0.07-371.43%
2019-09-302019-11-18$24.24 million-$0.73-$3.4278.66%

Frequency Therapeutics, Inc (FREQ) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Frequency Therapeutics, Inc (FREQ) Chart:

Frequency Therapeutics, Inc (FREQ) News:

Below you will find a list of latest news for Frequency Therapeutics, Inc (FREQ) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Frequency Therapeutics, Inc (FREQ) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2030-12-18257.8CALL4 110FALSE3.30.73
2030-12-18150PUT 0TRUE00

Latest FREQ Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$1.165
Jun 13, 2022 7:59 PM EST27$1.18
Jun 13, 2022 7:59 PM EST30$1.18
Jun 13, 2022 7:59 PM EST70$1.18
Jun 13, 2022 7:59 PM EST14$1.18

Frequency Therapeutics, Inc (FREQ) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220020974/0001127602-20-020974-index.htm
2020-09-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1703647/000000000020008244/0000000000-20-008244-index.htm
2020-10-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1703647/000081413320000062/0000814133-20-000062-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319024830/0000899243-19-024830-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319024834/0000899243-19-024834-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319024835/0000899243-19-024835-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319024838/0000899243-19-024838-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319024839/0000899243-19-024839-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319025213/0000899243-19-025213-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319025214/0000899243-19-025214-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319025216/0000899243-19-025216-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319025217/0000899243-19-025217-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319025351/0000899243-19-025351-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319025352/0000899243-19-025352-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319028542/0000899243-19-028542-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319028543/0000899243-19-028543-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319028544/0000899243-19-028544-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924319028546/0000899243-19-028546-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924320000051/0000899243-20-000051-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924320002536/0000899243-20-002536-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924320018925/0000899243-20-018925-index.htm
2020-07-234/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000089924320020203/0000899243-20-020203-index.htm
2020-02-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220004958/0001127602-20-004958-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220005628/0001127602-20-005628-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220005635/0001127602-20-005635-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220005638/0001127602-20-005638-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220005641/0001127602-20-005641-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220005645/0001127602-20-005645-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220005650/0001127602-20-005650-index.htm
2020-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220013565/0001127602-20-013565-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220014027/0001127602-20-014027-index.htm
2020-04-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220014220/0001127602-20-014220-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220014478/0001127602-20-014478-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220014490/0001127602-20-014490-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220014596/0001127602-20-014596-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220015183/0001127602-20-015183-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220015778/0001127602-20-015778-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220015786/0001127602-20-015786-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220016284/0001127602-20-016284-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220017400/0001127602-20-017400-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220017820/0001127602-20-017820-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220017821/0001127602-20-017821-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220018455/0001127602-20-018455-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220018891/0001127602-20-018891-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220018893/0001127602-20-018893-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220019477/0001127602-20-019477-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220019478/0001127602-20-019478-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220019479/0001127602-20-019479-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220019480/0001127602-20-019480-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220019481/0001127602-20-019481-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220019507/0001127602-20-019507-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220020363/0001127602-20-020363-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220020974/0001127602-20-020974-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220022001/0001127602-20-022001-index.htm
2020-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220022045/0001127602-20-022045-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220022915/0001127602-20-022915-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220023081/0001127602-20-023081-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220023991/0001127602-20-023991-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220024702/0001127602-20-024702-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220024908/0001127602-20-024908-index.htm
2020-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220025709/0001127602-20-025709-index.htm
2020-09-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220025732/0001127602-20-025732-index.htm
2020-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220025734/0001127602-20-025734-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220026530/0001127602-20-026530-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220026567/0001127602-20-026567-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220026721/0001127602-20-026721-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220026930/0001127602-20-026930-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000112760220028050/0001127602-20-028050-index.htm
2019-10-04424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1703647/000119312519262758/0001193125-19-262758-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000119312519263787/0001193125-19-263787-index.htm
2019-10-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1703647/000119312519263924/0001193125-19-263924-index.htm
2019-10-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1703647/000119312519266284/0001193125-19-266284-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000119312519292456/0001193125-19-292456-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000119312520006301/0001193125-20-006301-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1703647/000119312520038095/0001193125-20-038095-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1703647/000119312520124859/0001193125-20-124859-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1703647/000119312520124862/0001193125-20-124862-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000119312520127683/0001193125-20-127683-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000119312520167188/0001193125-20-167188-index.htm
2020-07-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000119312520196443/0001193125-20-196443-index.htm
2020-08-28S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1703647/000119312520234689/0001193125-20-234689-index.htm
2020-09-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1703647/000119312520237353/0001193125-20-237353-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000119312520253994/0001193125-20-253994-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000119312520280415/0001193125-20-280415-index.htm
2019-10-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1703647/000119380519000909/0001193805-19-000909-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000119380519000911/0001193805-19-000911-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000156459019043669/0001564590-19-043669-index.htm
2019-11-1810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1703647/000156459019043670/0001564590-19-043670-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000156459020012976/0001564590-20-012976-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1703647/000156459020012977/0001564590-20-012977-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000156459020025267/0001564590-20-025267-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1703647/000156459020025273/0001564590-20-025273-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1703647/000156459020039485/0001564590-20-039485-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1703647/000156459020039488/0001564590-20-039488-index.htm
2020-07-27DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000156761920013720/0001567619-20-013720-index.htm
2019-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1703647/000172202419000022/0001722024-19-000022-index.htm
2019-10-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1703647/999999999519002226/9999999995-19-002226-index.htm
2020-09-03EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1703647/999999999520002362/9999999995-20-002362-index.htm

Frequency Therapeutics, Inc (FREQ) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Frequency Therapeutics, Inc (FREQ). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1249%
Institutional Ownership: 5792%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-20JOEL S MARCUSDirectorBuy55,555.0018.00999,990.001,011,730.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220022001/0001127602-20-022001-index.htm
2020-10-07Christopher R. LooseChief Scientific OfficerSell8,000.0020.00160,010.40103,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220026721/0001127602-20-026721-index.htm
2020-10-06Christopher R. LooseChief Scientific OfficerSell8,000.0019.46155,680.00111,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220026721/0001127602-20-026721-index.htm
2020-10-05Christopher R. LooseChief Scientific OfficerSell8,000.0018.35146,800.00119,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220026567/0001127602-20-026567-index.htm
2020-06-03Richard J. MitranoVP Finance & OperationsBuy929.000.0765.0312,463.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220018893/0001127602-20-018893-index.htm
2020-10-02Christopher R. LooseChief Scientific OfficerSell8,000.0018.92151,360.00127,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220026567/0001127602-20-026567-index.htm
2020-10-01Christopher R. LooseChief Scientific OfficerSell8,000.0018.84150,720.00135,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220026567/0001127602-20-026567-index.htm
2020-09-23Christopher R. LooseChief Scientific OfficerSell24.0022.43538.32143,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220025709/0001127602-20-025709-index.htm
2020-09-23Christopher R. LooseChief Scientific OfficerSell2,606.0021.5756,201.00143,806.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220025709/0001127602-20-025709-index.htm
2020-09-23Christopher R. LooseChief Scientific OfficerSell1,870.0020.5138,357.63146,412.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220025709/0001127602-20-025709-index.htm
2020-09-09Christopher R. LooseChief Scientific OfficerSell776.0019.2614,943.90148,282.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220024908/0001127602-20-024908-index.htm
2020-09-09Christopher R. LooseChief Scientific OfficerSell3,724.0018.9170,424.94149,058.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220024908/0001127602-20-024908-index.htm
2020-06-03Richard J. MitranoVP Finance & OperationsBuy2,552.000.611,556.7215,015.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220018893/0001127602-20-018893-index.htm
2020-08-19Christopher R. LooseChief Scientific OfficerSell4,500.0022.97103,349.70152,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220023991/0001127602-20-023991-index.htm
2019-10-07Richard J. MitranoVP Finance & OperationsBuy107.0014.001,498.0015,673.00https://www.sec.gov/Archives/edgar/data/1703647/000089924319025351/0000899243-19-025351-index.htm
2020-08-05Christopher R. LooseChief Scientific OfficerSell58.0021.911,270.70157,282.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220023081/0001127602-20-023081-index.htm
2020-08-05Christopher R. LooseChief Scientific OfficerSell4,442.0021.2194,193.05157,340.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220023081/0001127602-20-023081-index.htm
2020-07-22Christopher R. LooseChief Scientific OfficerSell4,500.0021.5196,790.50161,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220022045/0001127602-20-022045-index.htm
2020-07-08Christopher R. LooseChief Scientific OfficerSell779.0022.9717,891.29166,282.00https://www.sec.gov/Archives/edgar/data/1703647/000089924320018925/0000899243-20-018925-index.htm
2020-07-08Christopher R. LooseChief Scientific OfficerSell3,721.0022.1882,547.78167,061.00https://www.sec.gov/Archives/edgar/data/1703647/000089924320018925/0000899243-20-018925-index.htm
2020-06-24Christopher R. LooseChief Scientific OfficerSell4,500.0022.80102,586.95170,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220020363/0001127602-20-020363-index.htm
2020-06-10Christopher R. LooseChief Scientific OfficerSell4,500.0019.9689,829.00175,282.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220019507/0001127602-20-019507-index.htm
2019-10-07MARC A COHENDirectorBuy17,857.0014.00249,998.0017,857.00https://www.sec.gov/Archives/edgar/data/1703647/000089924319025352/0000899243-19-025352-index.htm
2020-05-20Christopher R. LooseChief Scientific OfficerSell1,832.0019.3335,408.35187,282.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220017821/0001127602-20-017821-index.htm
2020-05-20Christopher R. LooseChief Scientific OfficerSell2,668.0018.8250,202.16189,114.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220017821/0001127602-20-017821-index.htm
2020-05-06Christopher R. LooseChief Scientific OfficerSell554.0016.689,240.22191,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220015786/0001127602-20-015786-index.htm
2020-05-06Christopher R. LooseChief Scientific OfficerSell3,946.0016.2364,028.19192,336.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220015786/0001127602-20-015786-index.htm
2020-04-22Christopher R. LooseChief Scientific OfficerSell4,500.0014.8466,794.40196,282.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220014478/0001127602-20-014478-index.htm
2020-04-08Christopher R. LooseChief Scientific OfficerSell4,500.0014.9967,468.50200,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220013565/0001127602-20-013565-index.htm
2019-10-07James E Flynn10% Share HolderBuy285,714.0014.003,999,996.00285,714.00https://www.sec.gov/Archives/edgar/data/1703647/000119380519000911/0001193805-19-000911-index.htm
2020-05-21JOEL S MARCUSDirectorSell5,000.0018.8194,052.50319,700.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220017820/0001127602-20-017820-index.htm
2020-05-20JOEL S MARCUSDirectorSell5,000.0018.7693,795.50324,700.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220017400/0001127602-20-017400-index.htm
2020-05-19JOEL S MARCUSDirectorSell7,809.0018.40143,670.76329,700.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220017400/0001127602-20-017400-index.htm
2020-05-18JOEL S MARCUSDirectorSell15,000.0019.15287,188.50337,509.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220017400/0001127602-20-017400-index.htm
2020-11-02David L. LucchinoPresident and CEOSell2,749.0021.4158,856.09339,514.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220028050/0001127602-20-028050-index.htm
2020-11-02David L. LucchinoPresident and CEOSell12,965.0020.68268,116.20342,263.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220028050/0001127602-20-028050-index.htm
2020-10-01David L. LucchinoPresident and CEOSell4,878.0019.7196,145.38355,228.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220026530/0001127602-20-026530-index.htm
2020-10-01David L. LucchinoPresident and CEOSell10,838.0018.87204,513.06360,106.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220026530/0001127602-20-026530-index.htm
2020-09-01David L. LucchinoPresident and CEOSell3,586.0019.0568,318.32370,944.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220024702/0001127602-20-024702-index.htm
2020-09-01David L. LucchinoPresident and CEOSell12,128.0018.40223,155.20374,530.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220024702/0001127602-20-024702-index.htm
2020-08-03David L. LucchinoPresident and CEOSell15,714.0021.63339,829.39386,658.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220022915/0001127602-20-022915-index.htm
2020-07-01David L. LucchinoPresident and CEOSell15,714.0022.45352,832.73402,372.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220020974/0001127602-20-020974-index.htm
2020-06-02David L. LucchinoPresident and CEOSell3,839.0018.5771,276.41418,086.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220018891/0001127602-20-018891-index.htm
2020-06-01David L. LucchinoPresident and CEOSell11,875.0017.91212,653.94421,925.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220018455/0001127602-20-018455-index.htm
2020-05-08David L. LucchinoPresident and CEOSell10,478.0018.18190,494.23433,800.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220016284/0001127602-20-016284-index.htm
2020-05-05David L. LucchinoPresident and CEOSell5,239.0016.1984,834.60444,278.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220015778/0001127602-20-015778-index.htm
2019-12-30David L. LucchinoPresident and CEOBuy36,590.000.6122,319.90444,441.00https://www.sec.gov/Archives/edgar/data/1703647/000089924320000051/0000899243-20-000051-index.htm
2020-05-01David L. LucchinoPresident and CEOSell5,236.0015.2879,997.18449,517.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220015183/0001127602-20-015183-index.htm
2020-04-24David L. LucchinoPresident and CEOSell729.0016.3511,919.44454,753.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220014596/0001127602-20-014596-index.htm
2020-04-23David L. LucchinoPresident and CEOSell1,410.0016.0822,673.65455,482.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220014490/0001127602-20-014490-index.htm
2020-04-17David L. LucchinoPresident and CEOSell3,100.0016.0049,600.00456,892.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220014220/0001127602-20-014220-index.htm
2020-04-15David L. LucchinoPresident and CEOSell5,236.0015.1379,234.29459,992.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220014027/0001127602-20-014027-index.htm
2019-12-30David L. LucchinoPresident and CEOBuy20,787.000.6112,680.07465,228.00https://www.sec.gov/Archives/edgar/data/1703647/000089924320000051/0000899243-20-000051-index.htm
2020-01-30MARC A COHENDirectorBuy8,042.000.614,905.62525,746.00https://www.sec.gov/Archives/edgar/data/1703647/000089924320002536/0000899243-20-002536-index.htm
2020-01-30MARC A COHENDirectorBuy16,691.000.6110,181.51542,437.00https://www.sec.gov/Archives/edgar/data/1703647/000089924320002536/0000899243-20-002536-index.htm
2020-01-30MARC A COHENDirectorBuy21,827.003.3773,556.99564,264.00https://www.sec.gov/Archives/edgar/data/1703647/000089924320002536/0000899243-20-002536-index.htm
2020-01-30MARC A COHENDirectorBuy20,778.003.3770,021.86585,042.00https://www.sec.gov/Archives/edgar/data/1703647/000089924320002536/0000899243-20-002536-index.htm
2020-01-30MARC A COHENDirectorBuy20,778.003.3770,021.86605,820.00https://www.sec.gov/Archives/edgar/data/1703647/000089924320002536/0000899243-20-002536-index.htm
2020-10-13Christopher R. LooseChief Scientific OfficerSell8,000.0022.00176,000.0087,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220026930/0001127602-20-026930-index.htm
2020-10-08Christopher R. LooseChief Scientific OfficerSell8,000.0021.12168,960.0095,782.00https://www.sec.gov/Archives/edgar/data/1703647/000112760220026721/0001127602-20-026721-index.htm